转化生物医学

  • 国际标准期刊号: 2172-0479
  • 期刊 h 指数: 16
  • 期刊引用分数: 5.91
  • 期刊影响因子: 3.66
索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 期刊目录
  • 研究圣经
  • 全球影响因子 (GIF)
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 电子期刊图书馆
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
  • 研究之门
分享此页面

抽象的

Evaluating the Antibacterial Potential of Streptomyces sp.

Sujith Sugathan, Aseer Manilal, Tigist Gezmu, Behailu Merdekios, Joseph Selvin, Tsegaye Tsalla, Akbar Idhayadhulla and Shine Kadaikunnan

Background and Objectives: Marine bacteria are recognized as an untapped resource of bioactive metabolites of diverse structure and functions. The present research is focused on the screening of the antagonistic potential of bacteria isolated from marine sponge against human and shrimp pathogens.

Methods and Findings: In this study, a total of 51 strains of bacteria isolated from five species of marine sponges sourced from the Vizhinjam littoral (Indian Ocean) were screened for possible antagonistic activity against human and shrimp pathogens. Of the 51 bacterial isolates, twelve strains isolated from marine sponges, S.officinalis and D. nigra showed different ranges of activity. The results of agar-well diffusion assay showed that, out of the twelve strains, MAPS 15 strain showed the highest
activity which subdued the growth of all the tested 20 bacterial pathogens. The molecular characterization based on partial 16S rRNA sequence revealed that the active isolate MAPS 15 was Streptomyces sp.

Conclusion: This study serves as a basis for further research on the possibility of utilizing Streptomyces sp. for the development of human and veterinary grade antibiotics.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证